Search results
Transfer Saga: Besiktas & Lazio’s Ciro Immobile
The Laziali· 2 hours agoThis article followed the Transfer Saga concerning Besiktas’ interest in Lazio’s Ciro Immobile. The 34-year-old Italian striker was surprisingly linked...
7 Congress MLAs Cross-Voted In Key Maharashtra Polls: Sources
NDTV· 6 hours agoIn a worrying sign for the opposition Maha Vikas Aghadi in Maharashtra, which was riding high after...
Delhi stays dry despite rain forecast, maximum temperature hits 34.3 degrees Celsius
Indian Express· 6 hours agoThe city recorded a minimum temperature of 29.6 degrees Celsius.
BJP, Allies Sweep Maharashtra Legislative Council Poll, Win 9 Of 11 Seats
NDTV· 9 hours agoThe BJP-led Mahayuti alliance - consisting of Chief Minister Eknath Shinde's Shiv Sena and the NCP...
Guidebook to lighting up India’s renewable energy ambitions for upcoming Union Budget 2024 - The...
The Economic Times· 12 hours agoAs India sets its eyes on being a global green energy giant and achieving an installed renewable...
Nissan X-Trail teaser confirms 3-row seating & panoramic sunroof | Team-BHP
Team-BHP· 13 hours agoNissan has released yet another teaser of the upcoming X-Trail. The latest video confirms some of...
Thermax Q1 PAT seen up 59.3% YoY to Rs 148.4 cr: Motilal Oswal
CNBC Awaaz· 13 hours agoNet Sales are expected to increase by 13.9 percent Y-o-Y (down 20.4 percent Q-o-Q) to Rs 2,201 crore, according to Motilal Oswal.
Global Chinese sales rise 6% in June
Just Auto· 14 hours agoOverseas sales jumped by 174% to 203,404 units. Geely Auto six month global sales increased by 41% to 955,700 units and Great Wall Motor sales were 8%...
Maharashtra MLC Elections 2024: 11 Seats, 12 Candidates, And Resort Politics Amid Horse-Trading...
One India· 14 hours agoThe election for 11 Legislative Council seats in Maharashtra is poised to reshape the state's...
YolTech doses first subject in Phase I trial for YOLT-201 therapy
Clinical Trials Arena· 14 hours agoChina-based YolTech Therapeutics has dosed the first patient as part of its Phase I clinical trial...